(Q73929384)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9392622%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Growth inhibition of human ovarian cancers by cytotoxic analogues of luteinizing hormone-releasing hormone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9392622%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

3

A V Schally

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9392622%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

4

N Lamharzi

1 reference

7 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9392622%20AND%20SRC:MED&resulttype=core&format=json

author name string

M Miyazaki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9392622%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A Nagy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9392622%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

G Halmos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9392622%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

K Szepeshazi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9392622%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

K Groot

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9392622%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

P Armatis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9392622%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 December 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9392622%20AND%20SRC:MED&resulttype=core&format=json

Journal of the National Cancer Institute

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9392622%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9392622%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9392622%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

1803-1809

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9392622%20AND%20SRC:MED&resulttype=core&format=json

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

7 November 2019

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Gene structure and expression analysis of the epidermal growth factor receptor, transforming growth factor-alpha, myc, jun, and metallothionein in human ovarian carcinomas. Classification of malignant phenotypes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Melanotropin–daunomycin conjugate shows receptor-mediated cytotoxicity in cultured murine melanoma cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapeptyl Ovarian Cancer Study Group

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

A new human ovarian carcinoma cell line: establishment and analysis of tumor-associated markers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Long-term prognosis following macroscopic complete response at second-look laparotomy in advanced ovarian cancer patients treated with platinum-based chemotherapy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Evaluation of antitumor activity in a human breast tumor/nude mouse model with a special emphasis on treatment dose

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats by LH-RH antagonist Cetrorelix

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Cell surface actions of adriamycin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Determination of subcutaneous tumor size in athymic (nude) mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Analogues of luteinizing hormone-releasing hormone containing cytotoxic groups

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomata

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Characterization and Development of UCI 107, a Primary Human Ovarian Carcinoma Cell Line

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Cancer statistics, 1996.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

The anticancer agent adriamycin can be actively cytotoxic without entering cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Effect of luteinizing hormone-releasing hormone analogs containing cytotoxic radicals on growth of estrogen-independent MXT mouse mammary carcinoma in vivo

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Improved silver technique for showing nucleolar organiser regions in paraffin wax sections

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/JNCI/89.23.1803

Identifiers

DOI

10.1093/JNCI/89.23.1803

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9392622%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference